Functional maturation of dendritic cells by exposure to CD40L transgenic tumor cells, fibroblasts or keratinocytes

Cancer Letters

Volumn 168, Issue 2, 2001, Pages 145-154

  Felzmann, Thomas ^a   Buchberger, Maria ^a   Lehner, Manfred ^a   Printz, Dieter ^a   Kircheis, Ralf ^b   Wagner, Ernst ^b   Gadner, Helmut ^a   Holter, Wolfgang ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

Adenovirus enhanced transferrinfection; CD154; Gene transfer; Polyethylenimine

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 12; LIGAND; LIPOPOLYSACCHARIDE; TUMOR VACCINE;

ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KERATINOCYTE; LEUKOCYTE; LYMPHOCYTE; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY;

ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CANCER VACCINES; CD40 LIGAND; CELL COMMUNICATION; DENDRITIC CELLS; FIBROBLASTS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; KERATINOCYTES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MEMBRANE GLYCOPROTEINS; PLASMIDS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0035954824     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00526-2     Document Type: Article

References (24)

1. Immunobiology of dendritic cells
2. Capture and processing of exogenous antigens for presentation on MHC molecules
3. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
4. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
5. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
6. Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity
7. CD28/B7 system of T cells costimulation
8. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
9. Coupling of adenovirus to transferrin-polylysin/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes
10. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
11. Xenogenization by tetanus toxoid loading into lymphoblastoid cell lines and primary human tumor cells mediated by polycations and liposomes
12. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells
13. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway
14. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma
15. Gene transfer into hepatocytes using asialglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand
16. Human CD40-ligand: Molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production
17. Redundant control of adenovirus late gene expression by early region 4
18. Transferrin-polycation conjugates as carriers for DNA uptake into cells
19. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
20. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype
21. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
22. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages
23. Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes
24. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes